Equillium, Inc. EQ
1.51 USD +0.01 (+0.67%)
Nov 10, 2026, 10:31 AM EST
1.46 Day range 1.53
0.76 52-week range 3.54
- YTD
- -2.58%
- 1 year
- +55.67%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Revolution Medicines (NASDAQ:RVMD) stock rose 14.1% to $227.83 during Wednesday's after-market session. The market value of their outstanding shares is at $41.6 billion. As per the news, the…
benzinga.com Equillium Doses First Patient In Australia In Its Phase 1 Clinical Study Of EQ504 To Treat Serious Inflammatory Diseases Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that the first subject has been dosed in…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers SciSparc (NASDAQ:SPRC) shares moved upwards by 39.4% to $1.52 during Monday's pre-market session. Xencor (NASDAQ:XNCR) stock moved upwards by 29.46% to $32.6. The company's market cap stands…
benzinga.com Leerink Partners Assumes Equillium at Outperform, Announces Price Target of $6 Leerink Partners analyst Will Soghikian assumes Equillium (NASDAQ:EQ) with a Outperform rating and announces Price Target of $6.
benzinga.com Piper Sandler Initiates Coverage On Equillium with Overweight Rating, Announces Price Target of $20 Piper Sandler analyst Yasmeen Rahimi initiates coverage on Equillium (NASDAQ:EQ) with a Overweight rating and announces Price Target of $20.- benzinga.com Leerink Partners Upgrades Equillium to Outperform, Raises Price Target to $6 Leerink Partners analyst Thomas Smith upgrades Equillium (NASDAQ:EQ) from Market Perform to Outperform and raises the price target from $1 to $6.
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com Equillium Q1 EPS $(0.06) Misses $(0.05) Estimate Equillium (NASDAQ:EQ) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 75 percent increase over losses of $(0.24) per…
benzinga.com B. Riley Securities Initiates Coverage On Equillium with Buy Rating, Announces Price Target of $6 B. Riley Securities analyst William Woods initiates coverage on Equillium (NASDAQ:EQ) with a Buy rating and announces Price Target of $6.
benzinga.com Raymond James Initiates Coverage On Equillium with Strong Buy Rating, Announces Price Target of $6 Raymond James analyst Martin Auster initiates coverage on Equillium (NASDAQ:EQ) with a Strong Buy rating and announces Price Target of $6.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session - benzinga.com Cantor Fitzgerald Initiates Coverage On Equillium with Overweight Rating, Announces Price Target of $10 Cantor Fitzgerald analyst Emma Nealon initiates coverage on Equillium (NASDAQ:EQ) with a Overweight rating and announces Price Target of $10.
- benzinga.com Equillium Q4 EPS $(0.04) Beats $(0.14) Estimate Equillium (NASDAQ:EQ) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.14) by 70.37 percent. This is a 75 percent increase over losses of $(0.16) per…
- benzinga.com Roth Capital Initiates Coverage On Equillium with Buy Rating, Announces Price Target of $12 Roth Capital analyst Adam Walsh initiates coverage on Equillium (NASDAQ:EQ) with a Buy rating and announces Price Target of $12.
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session 
benzinga.com Why Is Equillium Stock Soaring Monday? Equillium stock is trading higher Monday after the company announced up to $50 million in financing through a securities purchase agreement with investors to advance EQ504.
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com Gold Down Over 2%; Monday.com Shares Tumble After Q2 Results 
benzinga.com US Stocks Mixed; Owens & Minor Posts Downbeat Earnings - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com Equillium Announces Strategic Expansion To Integrate Cryptocurrency Treasury Reserve Strategy As Part Of Its Broader Financial And Growth Objectives Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced a strategic expansion to integrate a…
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com Leerink Partners Downgrades Equillium to Market Perform, Lowers Price Target to $1 Leerink Partners analyst Thomas Smith downgrades Equillium (NASDAQ:EQ) from Outperform to Market Perform and lowers the price target from $3 to $1.
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results 
benzinga.com Penny Stock Equillium Falls After Itolizumab Treatment Fails To Show Improvement In Response Rates In Graft Versus Host Disease Patients Equillium's itolizumab showed improved longer-term outcomes in aGVHD despite missing primary endpoints. FDA feedback on potential Accelerated Approval is expected in May.
benzinga.com Nasdaq Down Over 100 Points; US Initial Jobless Claims Fall - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
- benzinga.com Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com US Stocks Lower; Donaldson Earnings Beat Views
- benzinga.com Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session